Antengene Announces 2025 Interim Results with Encouraging Clinical Data and Progress in TCE Platform

Forward-looking Statements: Forward-looking Statements: For details on forward-looking statements, please refer to our full Interim Results press release on the Company's website:https://www.antengene.com/newsinfo/442     For more information, please contact: Investor Contacts: Donald LungE-mail:[email protected]  Mobile: +86 18420672158 PR Contacts:Peter QianE-mail:[email protected]   Mobile: +86 13062747000 Logo -https://mma.prnewswire...

Forward-looking Statements:

For details on forward-looking statements, please refer to our full Interim Results press release on the Company's website: https://www.antengene.com/newsinfo/442   

For more information, please contact:

Investor Contacts: 
Donald Lung
E-mail: [email protected]  
Mobile: +86 18420672158

PR Contacts:
Peter Qian
E-mail: [email protected] 
Mobile: +86 13062747000

Logo - https://mma.prnewswire.com/media/2355066/ANTENGENE_EN_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/antengene-announces-2025-interim-results-with-encouraging-clinical-data-and-progress-in-tce-platform-302537315.html